Timo Vaara
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
- Microbiology top 1%
- Antimicrobial Peptides and Activities
Papers in
-
- Antibiotic Resistance in Bacteria 20
- Pharmacology 10
- Antibiotics Pharmacokinetics and Efficacy 10
- Co-authors
- Martti Vaara (27 shared papers)P. Helena Mäkelä (2 shared papers)J. Apajalahti (3 shared papers)Seppo Niemelä (1 shared paper)Michael C. Jensen (1 shared paper)Marjatta Nurminen (1 shared paper)Ilkka M. Helander (1 shared paper)E. Rietschel (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (6 papers)Journal of Antimicrobial Chemotherapy (5 papers)Peptides (4 papers)Canadian Journal of Microbiology (3 papers)Journal of Bacteriology (2 papers)
- Partner nations
- FinlandUnited StatesDenmark
In The Last Decade
Timo Vaara
34 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 104
- Molecular Medicine 829
- Microbiology 405
- Endocrinology 141
- Pharmacology 422
- Applied Microbiology and Biotechnology 48
Countries citing papers authored by Timo Vaara
This map shows the geographic impact of Timo Vaara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timo Vaara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timo Vaara more than expected).
Fields of papers citing papers by Timo Vaara
This network shows the impact of papers produced by Timo Vaara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timo Vaara. The network helps show where Timo Vaara may publish in the future.
Co-authors
The 25 scholars most cited alongside Timo Vaara, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1983 | 224 | |
| 2 | 1983 | 209 | |
| 3 | 1983 | 196 | |
| 4 | 1981 | 182 | |
| 5 | 2008 | 119 | |
| 6 | 1995 | 110 | |
| 7 | 2010 | 104 | |
| 8 | 1981 | 98 | |
| 9 | 1979 | 80 | |
| 10 | 1979 | 74 | |
| 11 | 2018 | 72 | |
| 12 | 1984 | 51 | |
| 13 | 1982 | 41 | |
| 14 | 1988 | 40 | |
| 15 | 1994 | 40 | |
| 16 | 2012 | 36 | |
| 17 | 2009 | 34 | |
| 18 | 2010 | 31 | |
| 19 | 1980 | 30 | |
| 20 | 1983 | 29 |
About Timo Vaara
Timo Vaara is a scholar working on Molecular Medicine, Pharmacology, Epidemiology, Molecular Biology and Renewable Energy, Sustainability and the Environment, having authored 34 papers that have together received 2.0k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (20 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers), Algal biology and biofuel production (6 papers), Pneumocystis jirovecii pneumonia detection and treatment (6 papers), Antimicrobial Peptides and Activities (4 papers), Biocrusts and Microbial Ecology (3 papers), Vibrio bacteria research studies (2 papers) and Aquatic Ecosystems and Phytoplankton Dynamics (2 papers). The work is most often cited by research in Molecular Medicine (829 citations), Microbiology (405 citations), Endocrinology (141 citations), Pharmacology (422 citations) and Applied Microbiology and Biotechnology (48 citations). Timo Vaara has collaborated with scholars based in Finland, United States and Denmark. Frequent co-authors include Martti Vaara, P. Helena Mäkelä, J. Apajalahti, Seppo Niemelä, Michael C. Jensen, Marjatta Nurminen, Ilkka M. Helander, E. Rietschel, Niels Frimodt‐Møller and Matti Sarvas. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy, Peptides, Canadian Journal of Microbiology and Journal of Bacteriology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.